Goibela (Dydrogesterone)

Goibela is indicated for several reproductive health conditions where progestogenic support is required.

• Luteal phase support in assisted reproductive technologies such as in vitro fertilization.
• Treatment of menstrual disorders associated with progesterone deficiency, including irregular cycles and amenorrhea.
• Management of infertility related to luteal phase insufficiency.
• Support in early pregnancy to help prevent miscarriage in women with a history of recurrent loss.
• Hormone therapy for women with luteal phase deficiency undergoing ovulation induction protocols.
• Adjunctive treatment in women experiencing premenstrual syndrome where progesterone supplementation may alleviate symptoms.

Goibela, like other progestogens, may cause a range of side effects that vary in frequency and severity.

Common

• Nausea or mild gastrointestinal discomfort.
• Breast tenderness or swelling.
• Headache or mild dizziness.
• Mood changes such as irritability or mild depression.
• Fluid retention leading to mild swelling of the ankles.
• Decreased libido or sexual desire.
• Weight gain or increased appetite.

Serious

• Signs of venous thromboembolism, such as leg pain, swelling, or shortness of breath.
• Severe allergic reactions, including rash, itching, swelling of the face or throat, and difficulty breathing.
• Unusual vaginal bleeding or spotting.
• Liver dysfunction indicated by jaundice or dark urine.
• Persistent abdominal pain that may indicate gallbladder disease.

When prescribing Goibela, healthcare professionals consider several precautions to ensure safe use and to minimize risks.

• Evaluate for a history of thromboembolic disorders before initiating therapy.
• Assess liver function, as hepatic impairment may affect drug metabolism.
• Use caution in patients with known hormone-sensitive cancers such as breast or endometrial carcinoma.
• Monitor for signs of depression or mood disorders during treatment.
• Consider the potential for fluid retention in individuals with hypertension or cardiac disease.
• Review any history of allergic reactions to progestogens.

Goibela may interact with other medications, influencing its effectiveness or increasing the risk of adverse effects.

Avoid

• Combined use with other hormonal contraceptives or progestogenic agents, which can increase progestogenic load.
• Concomitant administration of strong CYP3A4 inducers (e.g., rifampicin, phenytoin) that may reduce dydrogesterone plasma levels.

Use with caution

• Anticoagulants such as warfarin, where progestogens may alter coagulation parameters.
• Antidepressants, particularly SSRIs, which can affect mood-related side effects.
• Medications that cause fluid retention (e.g., corticosteroids), potentially enhancing edema.
• Herbal supplements like St. John’s wort, a CYP3A4 inducer that could lower drug exposure.